CapsoVision, Inc. (NASDAQ:CV) Short Interest Up 171.0% in December

CapsoVision, Inc. (NASDAQ:CV) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totaling 215,141 shares, a growth of 171.0% from the November 30th total of 79,381 shares. Based on an average daily volume of 607,389 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.5% of the shares of the stock are short sold. Currently, 0.5% of the shares of the stock are short sold. Based on an average daily volume of 607,389 shares, the days-to-cover ratio is currently 0.4 days.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Benchmark reiterated a “speculative buy” rating on shares of CapsoVision in a report on Friday, November 14th. Zacks Research upgraded CapsoVision to a “hold” rating in a report on Wednesday, November 5th. Roth Capital set a $7.00 price objective on CapsoVision in a report on Tuesday, November 4th. Finally, Weiss Ratings reiterated a “sell (e)” rating on shares of CapsoVision in a research note on Monday. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, CapsoVision currently has an average rating of “Moderate Buy” and an average price target of $6.00.

CapsoVision Trading Down 6.3%

Shares of CV traded down $0.87 during trading hours on Friday, hitting $13.01. The stock had a trading volume of 58,836 shares, compared to its average volume of 394,858. The stock has a fifty day simple moving average of $7.35. CapsoVision has a 12-month low of $3.43 and a 12-month high of $15.37.

CapsoVision (NASDAQ:CV) last announced its quarterly earnings results on Thursday, November 13th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.03). The business had revenue of $3.54 million during the quarter.

Institutional Trading of CapsoVision

An institutional investor recently bought a new position in CapsoVision stock. New York State Common Retirement Fund acquired a new stake in shares of CapsoVision, Inc. (NASDAQ:CV) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 7,114 shares of the company’s stock, valued at approximately $34,000.

CapsoVision Company Profile

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.